About the Journal

Focus and Scope

Lumina: Indonesian Journal of Neurology is an open-access, peer-reviewed journal dedicated to advancing the field of neurological sciences, with a focus on both basic neuroscience and clinical neurology. The journal publishes original research, reviews, and intriguing case reports. It also welcomes brief communications that highlight recent advancements in diagnostic techniques, treatments, or other relevant neurological health issues. Additionally, letters and commentaries on previously published articles are encouraged.

Topics for publication include, but are not limited to:

    • Neuroepidemiology
    • Neurovascular
    • Neurophysiology
    • Epilepsy
    • Sleep disorders
    • Neurobehavior
    • Neuroimmunology
    • Neurodegenerative diseases
    • Neurootology
    • Neuroophthalmology
    • Neuropediatrics
    • Neurointervention
    • Neuroradiology
    • Neurorestoration
    • Movement disorders
    • Pain management and interventions
    • Neuroendocrinology
    • Neurosurgery
    • Neuropathology
    • Neuroinfection
    • Neuroanesthesiology
    • Neurooncology
    • Neuropharmacology
    • Neuroanatomy

Peer Review Process

Lumina: Indonesian Journal of Neurology implements a Double-Blind Peer Review process to ensure fairness, objectivity, and academic integrity in scientific publishing. Under this policy, the identities of both the reviewers and the authors remain strictly concealed from each other throughout the review workflow. This process is guided by the following principles:

  1. Mutual Anonymity: Reviewers evaluate manuscripts without knowledge of the authors' names, affiliations, or biographical details. Correspondingly, authors are not informed of the reviewers' identities.

  2. Objective Assessment: Anonymized evaluation minimizes potential biases related to author seniority, academic reputation, gender, nationality, or institutional affiliation.

  3. Blinded Manuscript Preparation: Authors must submit an anonymized main text file (devoid of author names, affiliations, acknowledgments, or self-identifying citations) alongside a separate Title Page containing complete author details and declarations.

  4. Ethical Compliance & Confidentiality: All reviewers and editors must treat submitted manuscripts as confidential documents and adhere strictly to standard publication ethics.

Policy History Note:

Starting from Volume 2, Issue 3 (6th Issue), the journal transitioned to a Double-Blind Peer Review model to enhance evaluation objectivity and align with international publication standards. Previous issues (Issues 1–5) were published under an Open Peer Review system.

Review Process Stages:

  1. Submission and Technical Check: Manuscripts are first checked to ensure they meet formatting and ethical standards.
  2. Initial Editorial Review: The editorial team assesses whether the manuscript is appropriate for the journal’s scope.
  3. Assignment to an Editor: If appropriate, an Editor is assigned to manage the peer review process.
  4. Reviewer Selection: The Editor selects reviewers who are experts in the relevant field to evaluate the manuscript.
  5. Review Process: Reviewers provide detailed feedback on the manuscript’s quality, validity, and contribution.
  6. Author Revisions: Authors revise the manuscript based on reviewer feedback, which may involve multiple rounds of revision.
  7. Final Decision: The Editor makes a final decision based on reviewers’ suggestions and the revisions. Possible outcomes include:
    • Accepted as is: The manuscript is accepted for publication without changes.
    • Accepted with Minor Revisions: The manuscript is accepted with minor revisions within a specified timeframe.
    • Accepted with Major Revisions: The manuscript is accepted after significant revisions are made by the authors within a specified timeframe.
    • Resubmit (conditional rejection): The manuscript may be reconsidered after major revisions.
    • Rejected (outright rejection): The manuscript is not accepted for publication, even with major revisions.
  1. Publication: Accepted manuscripts are copyedited, formatted, and published. Plagiarism screening for submissions is conducted using the Turnitin application.

Publication Frequency

Lumina: Indonesian Journal of Neurology publishes three times a year, in April, August, and December.

Open Access Policy

This journal offers immediate open access to its content based on the belief that freely sharing research with the public fosters a broader global exchange of knowledge. Authors retain copyright over their articles and grant third parties the right to use, reproduce, and distribute the articles in accordance with the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0).

Author Fees and Publication Charges Policy

Lumina: Indonesian Journal of Neurology is an open-access journal. The submission, review process, and publication are all free of charge. Full articles can be read and downloaded at no cost from this site.

  • Article Submission Fee: 0.00 (IDR) or 0.00 (USD). Authors are not required to pay a submission fee as part of the submission process to cover review costs.
  • Review Fee. The journal offers two review options:
  1. Regular Review: 0.00 (IDR) or 0.00 (USD) - No fee is required for authors choosing the regular review process.
  1. Fast-Track Review: 0.00 (IDR) or 0.00 (USD) - This expedited review option is available upon request from the authors.
  • Article Publication Fee: 0.00 (IDR) or 0.00 (USD)

If an article is accepted for publication, authors are not required to pay a publication fee to cover publishing costs.

All fees are covered by the Department of Neurology of the Faculty of Medicine of Universitas Pelita Harapan . We extend our thanks to the organizers of Lumina: Indonesian Journal of Neurology and the Department of Neurology of the Faculty of Medicine of Universitas Pelita Harapan.

Author Self-Archiving Policy

Lumina: Indonesian Journal of Neurology is published under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0). Under this license, authors are permitted and encouraged to self-archive their work at any stage of the publication process.

Authors may deposit and share:

  • Preprints (pre-review versions) in institutional repositories, subject repositories, or personal/institutional websites at any time, including before and during submission.
  • Accepted manuscripts (post-peer-review, pre-copyedited versions) immediately upon acceptance, without any embargo period.
  • Published versions (Version of Record) immediately upon publication, as the journal provides immediate open access.

When self-archiving, authors must:

  • Acknowledge Lumina: Indonesian Journal of Neurology as the original publication venue.
  • Provide a link to the published article using its DOI.
  • Distribute the archived work under the same CC BY-SA 4.0 license terms, including any adaptations or derivative works.

This policy supports open science initiatives and maximizes the visibility, accessibility, and reuse of published research.

Competing Interest Policy

Authors, reviewers, and editors must disclose any financial, personal, or professional conflicts of interest that could influence their work. This includes funding sources, affiliations, or relationships that may affect objectivity. All competing interests will be stated in the published article to ensure transparency. 

Copyright Policy

Authors who publish with Lumina: Indonesian Journal of Neurology retain full copyright to their work while granting the journal the right of first publication. By submitting their work, authors agree to the following conditions:

  • Licensing: The work is simultaneously licensed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0). Authors grant the journal a non-exclusive license to publish, distribute, and archive the work. This license permits others to share, remix, adapt, and build upon the work, even for commercial purposes, provided appropriate credit is given to the original authors and the source, and derivative works are distributed under the same license terms.

  • First Publication Rights: Lumina: Indonesian Journal of Neurology holds the right to be the first publisher of all accepted manuscripts.

  • Author Rights & Self-Archiving: Authors retain the right to distribute, share, and deposit all versions of their manuscript (preprint, accepted author manuscript, and final published Version of Record) in personal, institutional, or disciplinary repositories without embargo, in accordance with our Self-Archiving Policy.

Please visit the Creative Commons website for more information about the CC BY-SA 4.0 License: https://creativecommons.org/licenses/by-sa/4.0/ 

Ethics and Misconduct Policy

All submitted papers containing animal experiments and/or involving human subjects should have obtained approval from an independent ethics committee. As mentioned above, the approval copy should be provided to the editorial office.

Use of Artificial Intelligence (AI) Policy

In accordance with the Committee on Publication Ethics (COPE) guidelines, Lumina: Indonesian Journal of Neurology adheres to strict ethical standards regarding the use of generative AI and AI-assisted technologies:

  • Authorship: Generative AI tools (such as ChatGPT or Large Language Models) cannot be listed or cited as authors or co-authors, as AI cannot assume ethical responsibility or legal accountability for submitted work.

  • Content Generation: AI tools must not be used to produce original scientific text, generate clinical insights, interpret diagnostic findings, or formulate conclusions.

  • Permissible Use & Disclosure: AI assistance is strictly permitted only for improving language readability, grammar refinement, and spelling corrections. Authors who utilize AI for these purposes must transparently disclose the tool's name, version, manufacturer, and specific scope of use in a dedicated section before the References. If no AI tools were used, an explicit declaration stating so must be included in the manuscript. Authors remain fully accountable for the integrity, accuracy, and originality of their entire submission.

Advertising Policy

We accept advertisements relevant to the medical and scientific community. Advertisements must align with our ethical values and should not mislead or promote unverified claims. The editorial process remains independent of any advertising influence, ensuring the integrity of published content.

Informed Consent Policy

For each article submitted to Lumina: Indonesian Journal of Neurology, informed consent must be obtained from every participant involved in the study. Informed consent refers to the written permission provided by a patient or their legally authorized representative, approving the publication of any information, images, or case details related to the patient's clinical condition.

Authors must state explicitly in the manuscript whether informed consent was obtained, including consent to publish identifiable information or images of the individuals involved. The journal editor may request a copy of the informed consent documentation at any stage of the review or publication process.

Patient confidentiality must be maintained in accordance with all applicable data protection and privacy regulations. Where complete anonymization is not possible, authors must obtain explicit written consent from the patient or their representative before submission. If a patient has died, consent must be obtained from their next of kin or legally authorized representative.

For studies involving minors, consent must be obtained from a parent or legal guardian. Assent should also be sought from the minor where appropriate, in accordance with local ethical standards.

The informed consent and patient confidentiality policies of Lumina: Indonesian Journal of Neurology align with all applicable data and privacy protection regulations, including the Fourth Amendment of the 1945 Constitution of the Republic of Indonesia, Article 28(G), as well as internationally recognized ethical standards for medical research involving human subjects.